Sartorius is a leading international partner of biopharma research and manufacturing. We help our customers simplify progress from drug discovery to manufacturing so that more people can have access to better medicine. And simplifying progress starts with our employees who move things forward by realizing ambitious ideas and growing alongside with the company. Our product portfolio covers two customer groups: With innovative laboratory instruments and consumables, Sartorius focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. Our broad bioprocess product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. Based in Göttingen, Germany, Sartorius also has a strong global reach with more than 60 production and sales sites worldwide. We regularly expand our portfolio through the acquisition of complementary technologies. In 2025, Sartorius generated sales revenue of around 3.5 billion euros. Currently, more than 14,000 employees from 110+ nations are working for customers around the globe. Join our team, partner or collaborate with us.
Unlock the market timeline & signal feed
301 signals in the last 90 days.
The order this company entered each market — oldest to newest
💡Exclusive SG Workshop: Is Your Contamination Control Strategy Truly Integrated?Beyond the barrier lies the future of sterility assurance. Come join Sartorius & SKAN industry experts in a live, actionable session. Walk away with:➤ Clear steps to align technology with microbial control➤ Tactics to cut validation time and avoid regulatory pitfalls➤ Real-world answers to your toughest sterility challengesRegister today! https://sar.to/qiq02 ...
R&D Field Account Manager Strategic Accounts
Sign up to see the full signal feed
How Sartorius's international expansion compares to its competitors
SartoriusYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 SartoriusYou | 25 | 0 | -52% | 290 | 37 |
Scaling fast — 255 roles opened in the last 90 days, up 154% vs the prior period. Engineering-led and concentrated in Germany.
Buenos Aires, Buenos Aires Province, Argentina · 3d ago
Technical Sales Specialist
Göttingen, Lower Saxony, Germany · 4d ago
Lab Weighing Technician (x|w|m)
United States · 4d ago
Product Manager, ATS Services
59 technologies detected across the stack.
11 active campaigns across 179 markets.
Ended
Ended7 mentions in the last 90 days.
Sartorius Picus NxT electronic pipette offers precise liquid handling from 0.2-10,000 µl with lightweight design, electronic control, multiple channel options, and ISO-certified calibration for research and biopharma applications.
German DAX index fell 0.34% to 26,002 points amid rising bond yields and oil prices. Tonies shares dropped 4.6% despite revenue growth, while Sartorius gained 5.1% on UBS upgrade.
UBS analyst Matthew Weston upgraded Sartorius to Buy from Neutral, raising price target to €300. Strong growth expected in Bioprocess Solutions driven by consumables demand and US production relocation.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Sartorius's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
